| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Protein Chemistry [A. C., V. A. N.], Department of Molecular Biology and Microbiology, Tufts University School of Medicine, and The Department of Pediatrics [V. A. N.] and Medicine [V. L., W. H. C.], New England Medical Center, Boston, Massachusetts 02111
The phagocytic activity of three types of leukemic cells was studied for Staphylococcus aureus in physiological Krebs-Ringer phosphate glucose medium alone, and after stimulation with autologous complement-inactivated serum and with phagocytosis-stimulating tetrapeptide, "tuftsin." The level of tuftsin activity in the sera of patients was also evaluated. Fifteen patients were included in this study: six with myelofibrosis, seven with acute granulocytic leukemia, and two with myelomonocytic leukemia. In all six cases of myelofibrosis, the polymorphonuclear cells showed a normal level of basal phagocytosis in Krebs-Ringer phosphate glucose medium. Five of seven cases of acute granulocytic leukemia showed normal or near-normal values also, while two had significantly diminished levels. All thirteen of these patients failed to show stimulation with saturating amounts of autologous serum or tuftsin. This is distinctly abnormal, since normal blood granulocytes of humans, dogs, and rabbits are considerably stimulated. The two cases of myelomonocytic leukemia available for study showed a higher than normal basal phagocytic activity in Krebs-Ringer phosphate glucose medium and responded normally to serum and tuftsin stimulation.
1 Supported by Grant AI-09116, NIH, USPHS, and Grant GB-31535 X, National Science Foundation.
2 American Cancer Society Professor of Molecular Biology (MA Division), to whom reprint requests should be addressed, at Division of Protein Chemistry, Tufts University School of Medicine, 136 Harrison Avenue, Boston, Mass. 02111.
Received 8/14/72. Accepted 3/ 5/73.
This article has been cited by other articles:
![]() |
F Trevisani, E Castelli, F G Foschi, M Parazza, E Loggi, M Bertelli, C Melotti, M Domenicali, G Zoli, and M Bernardi Impaired tuftsin activity in cirrhosis: relationship with splenic function and clinical outcome Gut, May 1, 2002; 50(5): 707 - 712. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |